Biotech entity

Biological World Model

Technology

funding is the sole category represented across all 1 tracked stories. Biological World Model is most often covered alongside Aureka Biotechnologies, which appears in 1 of these 1 story. Biological World Model appears in 1 tracked Biotech story from August 11, 2026.

Last mentioned: Aug 11, 2026

Entity pulse

Recent coverage · Biological World Model

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Biological World Model

funding is the sole category represented across all 1 tracked stories. Biological World Model is most often covered alongside Aureka Biotechnologies, which appears in 1 of these 1 story. Biological World Model appears in 1 tracked Biotech story from August 11, 2026. The tracked stories average 2 original sources each.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Biological World Model. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Series B financing closed

    US$100 million Series B round closed, led by Granite Asia and a strategic investor, bringing total funding to nearly $200 million.

  2. Company founded

    Aureka Biotechnologies is founded as an AI-native TechBio company aiming to build biological world models.

Stories mentioning Biological World Model 1

Funding Positive

Aureka Biotech Raises $100M Series B for Biological Foundation Models

Aureka Biotechnologies closed a $100 million Series B to build a closed-loop AI infrastructure that integrates foundation models with high-throughput experiments. The funding aims to advance de novo molecular design and biological structure prediction, marking a shift from AI-as-tool to AI-as-platform in biopharma R&D.

2 sources

Biological World Model is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.